Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
about
Treatment of juvenile idiopathic arthritis: a revolution in carePrediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature reviewWhat does an adult rheumatologist need to know about juvenile idiopathic arthritis?Advances in the treatment of polyarticular juvenile idiopathic arthritisJuvenile Idiopathic Arthritis: Diagnosis and TreatmentGenome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis casesThe majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohortA commentary on TREAT: the trial of early aggressive drug therapy in juvenile idiopathic arthritis.Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis.Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.Polyarticular juvenile idiopathic arthritis - epidemiology and management approachesChildhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritisPatient-reported Outcomes across Categories of Juvenile Idiopathic ArthritisDynamic tracking of functional gene modules in treated juvenile idiopathic arthritis.Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment.Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients.Muscle strength, physical fitness and well-being in children and adolescents with juvenile idiopathic arthritis and the effect of an exercise programme: a randomized controlled trial.Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept CohortPredictors of juvenile idiopathic arthritis course.Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administrationTrends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.Update on the treatment of juvenile idiopathic arthritisWhole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritisDisease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry.Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritisAssessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists.Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab.Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways.TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.Clinical utility of etanercept in the treatment of arthritides in children and adolescents.Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.Update on biologicals for treatment of juvenile idiopathic arthritis.Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives.Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.X-linked agammaglobulinemia combined with juvenile idiopathic arthritis and invasive Klebsiella pneumoniae polyarticular septic arthritis.
P2860
Q26849497-830709B0-4CBE-4771-AFE6-6C4B310543F9Q26991741-D3B44AE9-E7A8-41C2-A17B-2AD7115ED348Q26995394-F7AE8284-3BA3-4B43-AD9B-6D1EB3F776BAQ27001017-92D23F2C-C439-4B7E-9F75-3B0AD4DCF621Q28079246-15620BCF-D387-4486-8D93-BBC70EB4BA21Q30795448-FD8039BA-A0C2-4B4F-8829-5513FB2958D6Q31033140-9596042A-EE9B-4BD5-82F7-66E1739089BDQ31064321-3989609F-55C9-4763-99E7-F2AC1DB91AEFQ31113750-3D43B887-8260-4004-A10E-FF8F64EEAEB2Q33440560-424340A2-1720-4C76-A10E-7674A314A57AQ33828973-06A7BAAA-57D9-4C21-A3B5-8BEC31A19F11Q34185017-20010555-7D5F-44BB-9FAC-F082B3229CF9Q34434750-E4619710-A451-4E66-880E-DC163FCC737CQ35743755-4730E2CA-35A5-4CF5-AA28-AAFAF2A7C579Q36118097-4AA6C4AB-A0DF-48B5-9120-8B0F65ADD852Q36203332-167CE693-71A0-4315-9F56-ACB9EDC03633Q36266841-940495D5-6F10-4344-9C6E-9691D02667E6Q36577387-B3792298-5BE9-42EC-A5AB-7DB12FA5B582Q36651293-55CA09E0-AED6-4353-881B-B742F43FCB38Q36735007-21F1D4F7-1ED5-4953-87E2-2E0DECE0D7C6Q36795982-E1ADE2A9-F7F7-41B6-B78F-86448E323916Q36842433-90542B4C-D426-4BCE-9514-9670B6985CBFQ37006464-18B5BDD6-81FA-45D5-B2F0-DB893A283DA8Q37014830-DDD3C1E0-168A-4C4B-B249-02B8E7044A74Q37060351-0980AB56-01FF-4948-9FE0-790B546A3D1AQ37073220-6C9CE467-A957-43AB-A476-6D1AFD8C6D09Q37147226-C9A28A9C-5CFB-428A-967A-F3A42D5FC24FQ37356217-5B367B50-9A60-422A-991D-35EA56602FAFQ37428914-350D4431-EB7C-4854-818A-846EED49E19BQ37436386-9E6D2449-DCF6-4C44-853A-435BA9FE6100Q37463702-2366E64C-9DD3-479D-A1E8-6590375F9A81Q37473831-F8FB0746-1665-4870-9C74-FD1D5487F2D6Q37616990-8AC77ECD-2CC8-485E-BFC4-D2253C4253B6Q37627929-A2B80813-68FC-4BC0-B66A-F8DCBB772DFEQ37676020-6A826449-33AB-4F02-91AD-33772F49A591Q38061615-1D84D968-02E0-4AB5-927C-7C35544FC8D9Q38071693-5E0A5773-A3D9-4391-B286-7FF2DE852B7BQ38092899-AD4FF54A-FDBA-458E-B38C-E0F2286DD404Q38144094-E21A46C8-C9DC-494E-9CD9-4A4CC355F310Q38190909-37C1BA62-F949-4749-B8FA-3BEAD15987E5
P2860
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@ast
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@en
type
label
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@ast
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@en
prefLabel
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@ast
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@en
P2093
P2860
P356
P1476
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
@en
P2093
Andrew S Zeft
Anne Johnson
Beth S Gottlieb
Carol A Wallace
Childhood Arthritis and Rheumatology Research Alliance
Daniel J Lovell
Diana Milojevic
Edward H Giannini
Gloria C Higgins
P2860
P304
P356
10.1002/ART.34343
P577
2011-12-19T00:00:00Z